Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Trospium Chloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,252Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bristol Myers Presents Long-term EMERGENT Data in Schizophrenia
    Bristol Myers Presents Long-term EMERGENT Data in Schizophrenia

    31 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241031061541/en

    BUSINESSWIRE
    31 Oct 2024
    Share Share
    Bristol Myers Squibb to Present Data at Psych Congress 2024
    Bristol Myers Squibb to Present Data at Psych Congress 2024

    28 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241025717199/en

    BUSINESSWIRE
    28 Oct 2024
    Share Share
    BMS' schizophrenia gem Cobenfy was salvaged from the scrapheap
    BMS' schizophrenia gem Cobenfy was salvaged from the scrapheap

    07 Oct 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/bmss-newly-approved-schizophrenia-drug-cobenfy-what-long-strange-trip-its-been

    FIERCE PHARMA
    07 Oct 2024
    Share Share
    Segal Trials Key In FDA Approval Of Cobenfy For Schizophrenia
    Segal Trials Key In FDA Approval Of Cobenfy For Schizophrenia

    04 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241003050509/en

    BUSINESSWIRE
    04 Oct 2024
    Share Share
    US FDA approves Bristol Myers' schizophrenia drug
    US FDA approves Bristol Myers' schizophrenia drug

    27 Sep 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-bristol-myers-schizophrenia-drug-2024-09-26/

    REUTERS
    27 Sep 2024
    Share Share
    Macleods Pharms Generic Trospium Chloride Receives Approval in US
    Macleods Pharms Generic Trospium Chloride Receives Approval in US

    18 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206472

    FDA
    18 Jun 2024
    Share Share